Consider whether symptoms might indicate: Underlying conditions being unmasked or worsening Effects of other supplements or medications Lifestyle factors like inadequate sleep, poor nutrition, or excessive stress Infections or illnesses unrelated to peptide use If symptoms do not match the expected AOD 9604 profile, persist after discontinuation, or are accompanied by other concerning signs, investigate independently rather than assuming the peptide is responsible
Starting GHK-CU during extreme weather, cold dry winter or hot humid summer, adds environmental stress to the adjustment period
Discard and start fresh, ensuring all equipment is sterile and your preservative system is adequate
RNA quality was assessed by Agilent 2100 Bioanalyzer using the RNA 6000 Nano Chip (Agilent Technologies, Amstelveen, The Netherlands), and RNA quantification was performed using ND-2000 Spectrophotometer (Thermo Inc., DE, USA)
Maintenance dose : 2 vials (600 mg x 2) every 12 hourly as intravenous injection for maximum of 7 days or earlier till the clinical improvement 4.3 Contraindications Glutathione injection is contraindicated in the patients who show hypersensitivity to reduced Glutathione